Showing results (1-10 of 70) with videos related to
Sort By:
Pageof 7
The Journal of Clinical Investigation|April 16, 2019
Are we there yet? The never-ending quest for an Epstein-Barr virus vaccineSandhya Sharma, Rayne H RouceFrontiers in Immunology|December 5, 2015
The Application of Natural Killer Cell Immunotherapy for the Treatment of CancerKatayoun Rezvani, Rayne H RouceCancer Discovery|June 5, 2016
Forecasting Cytokine Storms with New Predictive BiomarkersRayne H Rouce, Helen E HeslopMolecular Therapy : the Journal of the American Society of Gene Therapy|April 4, 2025
How to democratize cell and gene therapy: A global approachRayne H Rouce, Bambi J GrilleyBest Practice & Research. Clinical Haematology|August 23, 2023
Targeted cellular therapy for treatment of relapsed or refractory leukemiaLauren D Scherer, Rayne H RouceScience (New York, N.Y.)|August 1, 2024
Cell and gene therapy accessibilityRayne H Rouce, Matthew H PorteusHematology. American Society of Hematology. Education Program|December 4, 2020
Chimeric antigen receptor T cells for mature B-cell lymphoma and Burkitt lymphomaEmily M Hsieh, Rayne H RouceHematology. American Society of Hematology. Education Program|December 7, 2024
EBV and post-transplant lymphoproliferative disorder: a complex relationshipNader Kim El-Mallawany, Rayne H RouceBoletin Medico Del Hospital Infantil De Mexico|February 9, 2018
Recent advances in the risk factors, diagnosis and management of Epstein-Barr virus post-transplant lymphoproliferative diseasePaibel Aguayo-Hiraldo, Reuben Arasaratnam, Rayne H RouceThe Journal of Clinical Investigation|May 5, 2020
Replacing CAR-T cell resistance with persistence by changing a single residueEmily M Hsieh, Lauren D Scherer, Rayne H RoucePageof 7